Skip to Content

VentriPoint Diagnostics Ltd VPTDF

Morningstar Rating
$0.16 0.00 (0.12%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

VPTDF is trading within a range we consider fairly valued.
Price
$0.17
Fair Value
$4.96
Uncertainty
Extreme
1-Star Price
$2.58
5-Star Price
$6.12
Economic Moat
Wwlv
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if VPTDF is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.16
Day Range
$0.150.16
52-Week Range
$0.100.27
Bid/Ask
$0.14 / $0.16
Market Cap
$25.83 Mil
Volume/Avg
3,445 / 34,087

Key Statistics

Price/Earnings (Normalized)
Price/Sales
768.07
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

VentriPoint Diagnostics Ltd is a medical device company engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It develops applications for heart diseases and imaging modalities which includes congenital heart disease, left or right heart failure, and normal hearts. It sells its products in Canada and internationally.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Core
Total Number of Employees

Valuation

Metric
VPTDF
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
768.07
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
VPTDF
Quick Ratio
0.39
Current Ratio
0.42
Interest Coverage
Quick Ratio
VPTDF

Profitability

Metric
VPTDF
Return on Assets (Normalized)
−150.94%
Return on Equity (Normalized)
−342.13%
Return on Invested Capital (Normalized)
−257.57%
Return on Assets
VPTDF
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
PlswcgzcPynddt$186.6 Bil
Stryker Corp
SYK
SksrtfyyTyhq$129.7 Bil
Boston Scientific Corp
BSX
RmxzckqbLdyplrs$114.3 Bil
Medtronic PLC
MDT
DwgwltzbzHtghwvq$102.5 Bil
Edwards Lifesciences Corp
EW
DdjwmjqhnPzwvj$52.4 Bil
DexCom Inc
DXCM
RgtkmsxqkCdnk$44.3 Bil
Koninklijke Philips NV ADR
PHG
TpdyhcmwTklvn$24.4 Bil
Steris PLC
STE
JclqzctlVyyxzx$22.9 Bil
Zimmer Biomet Holdings Inc
ZBH
TsrpytbsqWyw$22.7 Bil
Align Technology Inc
ALGN
JhgnrhskhYbhjpw$18.4 Bil

Sponsor Center